Biomarkers in Heart Disease

Although the potential of biomarkers to enhance cardiovascular care is extremely bright, the challenge facing clinicians is determining how current and future biomarkers should be used in patient care, which is a fundamentally different process from early marker discovery. Biomarkers in Heart Disease is the first title in the AHA Clinical Series and is aimed at meeting the needs of clinicians, providing cardiologists, internists, emergency physicians, laboratorians, and other healthcare providers with a clear understanding of the role of biomarkers in contemporary cardiovascular medicine.

The book covers both the strengths and pitfalls of currently available markers, and provides information on the most promising biomarkers that are likely to impact practice in the next few years. It is divided into four parts, organized around clinical scenarios rather than individual biomarkers:

• biomarkers for the evaluation and management of patients with suspected acute and ischemic heart disease
  
• heart failure diagnosis and monitoring
  
• the increasingly important area of population screening
  
• where the field is moving in the future.

This book will help the practicing physician decide which biomarkers to measure, when to measure them, how to interpret the results and how to make decisions based on the test result.